| Literature DB >> 27344519 |
Andriy Didovyk1, Bartłomiej Borek1, Lev Tsimring2, Jeff Hasty3.
Abstract
CRISPR-Cas9 has recently emerged as a promising system for multiplexed genome editing as well as epigenome and transcriptome perturbation. Due to its specificity, ease of use and highly modular programmable nature, it has been widely adopted for a variety of applications such as genome editing, transcriptional inhibition and activation, genetic screening, DNA localization imaging, and many more. In this review, we will discuss non-editing applications of CRISPR-Cas9 for transcriptome perturbation, metabolic engineering, and synthetic biology.Entities:
Mesh:
Year: 2016 PMID: 27344519 PMCID: PMC4975649 DOI: 10.1016/j.copbio.2016.06.003
Source DB: PubMed Journal: Curr Opin Biotechnol ISSN: 0958-1669 Impact factor: 9.740